Monthly Archives: May 2024

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions MSN/2024/060 Tier 2 – medium impact Date of issue: 23rd May 2024 Shortages have been reported for clarithromycin 125mg/5ml and 250mg/5ml oral suspensions. Additional stock of clarithromycin 250mg/5ml is expected to be available in wholesalers [...]

The post Medicine Supply Notification: Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials MSN/2024/059 Tier 2 – medium impact Date of issue: 23rd May 2024 There will be intermittent supplies of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebules for the foreseeable future. Unlicensed supplies of salbutamol 2.5mg [...]

The post Medicine Supply Notification: Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (24/05/2024) confirmed the following initial list of price concessions for May 2024. This announcement comes late in the month and follows the decision by DHSC, under the direction of Ministers, to impose changes to concessions pricing from April 2024 to try to manage purchase margins. DHSC [...]

The post DHSC’s May 2024 Price Concessions – 1st Update appeared first on Community Pharmacy England.

Community Pharmacy England has issued the following statement in response to the Prime Minister’s announcement of a UK General Election. Our Chief Executive Janet Morrison said: “We have been preparing for the news of a UK General Election for many months, briefing and building support for community pharmacy across all political parties. That work remains [...]

The post UK General Election announced appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Sodium Chloride 0.9% Intravenous Infusion BP Freeflex and Freeflex PLUS (Fresenius Kabi Limited) Drug alert number: EL (24)A/17 Date issued: 22 May 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Sodium Chloride 0.9% Intravenous Infusion BP Freeflex and Freeflex PLUS [...]

The post MHRA Class 4 Medicines Notification: Sodium Chloride 0.9% Intravenous Infusion BP Freeflex and Freeflex PLUS (Fresenius Kabi Limited) appeared first on Community Pharmacy England.